The parity paradigm: Can legislation help reduce the cost burden of oral anticancer medications?

Sheetal M. Kircher*, Caitlin R. Meeker, Halla Nimeiri, Daniel M. Geynisman, S. Yousuf Zafar, Veena Shankaran, Jonas De Souza, Yu Ning Wong

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'The parity paradigm: Can legislation help reduce the cost burden of oral anticancer medications?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science